HealthEquity SG&A Expenses 2014-2024 | HQY

HealthEquity sg&a expenses for the twelve months ending October 31, 2024 were $0.214B, a 17.96% increase year-over-year.

  • HealthEquity annual sg&a expenses for 2024 were $0.183B, a 9.99% increase from 2023.
  • HealthEquity annual sg&a expenses for 2023 were $0.166B, a 15.47% increase from 2022.
  • HealthEquity annual sg&a expenses for 2022 were $0.144B, a 7.13% increase from 2021.

HealthEquity SG&A Expenses 2014-2024 | HQY

  • HealthEquity annual sg&a expenses for 2024 were $0.183B, a 9.99% increase from 2023.
  • HealthEquity annual sg&a expenses for 2023 were $0.166B, a 15.47% increase from 2022.
  • HealthEquity annual sg&a expenses for 2022 were $0.144B, a 7.13% increase from 2021.
Related Stocks
Company NameMarket
Cap
Elevance Health (ELV)$88.4B
Cencora (COR)$45.7B
Natera (NTRA)$23.1B
DiDi Global (DIDIY)$22B
ICON (ICLR)$18B
Avantor (AVTR)$14.7B
Viatris (VTRS)$13.9B
Revvity (RVTY)$13.9B
BioMerieux (BMXMF)$12.6B
CochLear (CHEOY)$12.1B
Solventum (SOLV)$11.6B
Medpace Holdings (MEDP)$10.9B
Doximity (DOCS)$9.7B
EUROFINS SCIENT (ERFSF)$9.7B
Charles River Laboratories (CRL)$9.5B
Sonic Healthcare (SKHHY)$8.2B
Bausch + Lomb (BLCO)$6.3B
Amplifon S.p.A (AMFPF)$5.9B
Organon (OGN)$4.1B
Sotera Health (SHC)$3.7B
BrightSpring Health Services (BTSG)$3B
Surgery Partners (SGRY)$2.6B
Concentras Parent (CON)$2.5B
GeneDx Holdings (WGS)$2.5B
Alignment Healthcare (ALHC)$2.3B
Ardent Health Partners (ARDT)$2.3B
Premier (PINC)$2B
PACS (PACS)$2B
GoodRx Holdings (GDRX)$1.7B
Teladoc Health (TDOC)$1.7B